Prostate Cancer Foundation 2018 Scientific Retreat

Prostate Cancer Foundation 2018 Scientific Retreat

INTERVIEW WITH ANDREA MIYAHIRA
The Prostate Cancer Foundation: A Discussion with Andrea Miyahira

VIEW ALL PCF VIDEOS

Prostate Cancer Foundation 2018 Scientific Retreat

Prostate Cancer Foundation 2018 Scientific Retreat

INTERVIEW WITH KENNETH PIENTA
The Process of Metastasis in Prostate Cancer

VIEW ALL PCF VIDEOS

European Society for Medical Oncology 2018 Congress

European Society for Medical Oncology 2018 Congress

INTERVIEW WITH FRED SAAD
A Renewed Analysis of ERA 223

VIEW ALL ESMO VIDEOS

Videos
State-of-the-industry video lectures by leading urology experts
Latest Videos
Featured Videos

ORLANDO, FL USA (UroToday.com) - Dr. Melise Keays from the Children’s Medical Center in Dallas (University of Texas, Southwestern) presented 2 observational studies on newborns with spina bifida. Both studies sought to characterize renal and bladder changes that may occur while low-risk patients are followed on an observational protocol for the first 3 years of life.

Newborns with spina bifida were followed with a standard protocol of video urodynamic study as part of their initial assessment at 3 months of age, 1 year, and 3 years. Renal ultrasound was performed at initial assessment and at 6 month intervals. Patients found to have a detrusor leak point pressure (DLPP) of < 40 cm were classified as “low risk” and placed on an observational protocol (instead of empiric clean intermittent catheterization and anti-cholinergic medication).

auaForty-eight of 57 (84%) newborns were identified as low risk at a mean of 3-months of age. Thirty-three percent of these patients had abnormalities at baseline: 10 (21%) with low-grade hydronephrosis (Society of Fetal Urology grade 1-2) and 8 (17%) with vesicoureteral reflux (VUR) of which most were low grade but one patient had grade V. Most patients resolved these upper tract changes over 12 months (7/10 with hydronephrosis and 5/8 with VUR).

Over time, 9 patients converted to a high-risk categorization with DLPP > 40cm. Of this group, 4 had no upper tract changes, 1 had stable hydronephrosis, 3 patients had new VUR and 1 had persistent VUR.

The second study (Renal damage in spina bifida patients on observation during the first three years of life) followed the same population but looked at renal changes on DMSA scans which were performed at the initial assessment, 1 year, 3 years, and with any febrile UTI. Cortical defects, with or without changes in renal function, were considered insults. In this population, 96% presented with a normal DMSA at baseline. Only 2 (4%) had decreased function but no cortical defects (“congenital nephropathy”). In the group of 9 patients that converted to a high-risk category, 3 were found to have new cortical defects. However, the authors note that one patient was inappropriately placed in the low-risk category at the beginning of the study. This patient had grade 5 VUR and, due to parent preference, was placed on observation. This patient ultimately converted to high risk and was found to have new renal scars with febrile UTIs.

The authors conclude that an observation protocol preserved renal status in 93% of these patients. Medical management can be delayed with little risk of long-term renal damage. One of the study authors, Dr. Micah Jacobs, notes that managing patients conservatively with observation is reasonable, but they need to be followed closely for adverse indicators of deterioration.

Presented by Melise Keays, MD at the Society for Pediatric Urology (SPU) Annual Meeting held concurrently with the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

Children’s Medical Center in Dallas (University of Texas, Southwestern), Dallas, Texas USA

Written by Michaella Prasad, MD of the Medical University of South Carolina, Charleston, and medical writer for UroToday.com

 

@UroToday
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe

Calendar
Upcoming educational events
January 24-27, 2019 / The Westin Riverfront at Beaver Creek
29th Annual International Prostate Cancer Update (IPCU)
February 1, 2019 / Thomas Jefferson University, Jefferson Alumni Hall, 1020 Locust Street, Philadelphia, PA
2nd Annual Jefferson Urology Symposium: Emerging Technologies for the Treatment of BPH